Posts tagged Hemispherx BioPharma Inc


Hemispherx BioPharma, Inc (HEB) Shares Soar on Positive Clinical Data

Hemispherx BioPharma, Inc (NYSEMKT:HEB) woke up to a nice 10% pop in the value of …

Hemispherx BioPharma, Inc (HEB) Announces Collaboration with Millions Missing Canada

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that on Thursday, August 3, 2017 it participated in a …

Hemispherx BioPharma, Inc (HEB) Highlights Cytokine Biomarker Discovery

Hemispherx BioPharma, Inc (NYSE MKT:HEB) said today that a new study led by a team …

Company Update (NYSEMKT:HEB): Hemispherx BioPharma, Inc Updates Status of Immuno-Oncology Program in Pancreatic Cancer

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that 12 pancreatic patients are currently undergoing treatment with single-agent …

Company Update (NYSEMKT:HEB): Hemispherx BioPharma, Inc Meets Ampligen Sales Milestone in the 1st Quarter of 2017

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced today that it has met a major milestone, the commencement …

Company Update (NYSEMKT:HEB): Here’s Why Hemispherx BioPharma, Inc Shares Are Diving 13% Today

This morning, Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that it has entered into definitive agreements with …

Company Update (NYSEMKT:HEB): Here Why Shares of Hemispherx BioPharma, Inc Rose 9%

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that the rintatolimod European early access program (EAP) designed to …

Company Update (NYSEMKT:HEB): Hemispherx BioPharma, Inc Announces Completion of Ampligen Manufacturing Technology Transfer Milestone

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that it has completed its technology transfer of the Ampligen® …

Show More